ID   HS_CRYL1     standard; region; VRT.
XX
AC   EP73886;
XX
DT   06-JAN-2003 (Rel. 73, created)
DT   13-SEP-2004 (Rel. 80, Last annotation update).
XX
DE   Crystallin, lambda 1.
OS   Homo sapiens (human).
XX
HG   none.
AP   none.
NP   none.
XX
DR   GENOME; NT_024524.13; NT_024524; [2079996, -65660329].
DR   CLEANEX; HS_CRYL1.
DR   EMBL; AL590096.16; [56254, -63620].
DR   SWISS-PROT; Q9Y2S2; CRYL1_HUMAN.
DR   RefSeq; NM_015974.
XX
RN   [1]
RX   MEDLINE; 11752328.
RA   Suzuki Y., Yamashita R., Nakai K., Sugano S.;
RT   "DBTSS: database of human transcriptional start sites and
RT   full-length cDNAs";
RL   Nucleic Acids Res. 30:328-331(2002).
XX
ME   NEDO full length human cDNA sequencing project.
ME   Oligo-capping [1].
XX
SE   ggtccgcgcgcgcagccaatgggcgcgggacccgccctccccggagcccAGAGCTCGCAG
XX
FL             DBTSS     MGC
IF   -5   A    1         none
IF    0   A    11
IF   +31  A    4
IF   +38  G    1
XX
TX   6. Vertebrate promoters
TX   6.1. Chromosomal genes
TX   6.1.7. Unclassified
XX
KW   none.
XX
FP   Hs CRYL1            :+R  EU:NC_000013.9       1-  19997996; 73886.
XX
DO        Experimental evidence: 11
DO        Expression/Regulation:
RF        NAR30:328
//